According to the EANO guideline for the treatment of patients with diffuse gliomas [21], combined temozolomide and radiotherapy followed by temozolomide maintenance treatment is recommended upon diagnosis of GBM regardless of IDH status at age under 70 years, the so-called ‘Stupp protocol’ [22]. The gene discussed is IDH2; the disease is glioblastoma.